Search results for " progress"

showing 10 items of 1287 documents

Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration

2005

Background: Frontotemporal lobar degeneration (FTLD) may be inherited as an autosomal dominant disease. Studying patients "at risk" for developing FTLD can provide insights into the earliest onset and evolution of the disease. Method: We carried out approximately annual clinical, MRI, and neuropsychological assessments on an asymptomatic 51 year old "at risk" family member from a family with FTLD associated with ubiquitin-positive and tau-negative inclusion bodies. We used non-linear (fluid) registration of serial MRI to determine areas undergoing significant regional atrophy at different stages of the disease. Results: Over the first 26 months of the study, the patient remained asymptomati…

PaperMalePathologymedicine.medical_specialtyDiseaseNeuropsychological TestsAsymptomaticBrain mappingAtrophy Brain/pathology Brain Mapping Dementia/pathology Disease Progression Female Follow-Up Studies Humans Male Middle Aged Neuropsychological TestsAtrophymental disordersmedicineHumansDementiaBrain MappingSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaNeuropsychologyfood and beveragesnutritional and metabolic diseasesBrainAutosomal dominant traitFrontotemporal lobar degenerationMiddle Agedmedicine.diseasenervous system diseasesPsychiatry and Mental healthDisease ProgressionDementiaFemaleSurgeryNeurology (clinical)Atrophymedicine.symptomPsychologyFollow-Up Studies
researchProduct

Neuroprotection in Parkinson's Disease: a Realistic Goal?

2010

The current issue of CNS Neuroscience & Therapeutics contains an interesting review by Kinecses and Vecsei [1] on the progress in our knowledge related to the pathophysiological mechanisms of Parkinson's disease (PD) and on the development of putative neuroprotective molecules. Since the seminal discovery by Oleh Hornykiewicz that degeneration of DA neurons within the substantia nigra pars compacta (SNc) and the consequential dopamine depletion in the striatum was the cause of neurological symptoms in PD [2], thousands of reviews have been written on the subject, some of them possibly superfluous. Nevertheless, we found this last work enjoyable in terms of readability and in the way the aut…

Parkinson's Disease neuroprotectionDisease Models AnimalNeuroprotective AgentsNeurologyDopamineDisease ProgressionAnimalsHumansParkinson DiseaseEdit0rialSettore BIO/09 - FisiologiaBiomarkers
researchProduct

Involvement of distal airways in a chronic model of experimental asthma.

2005

Summary Background Bronchial asthma is characterized by chronic airway inflammation and airway remodelling which occurs in both proximal and distal airways. These changes are associated with development of airway hyper-responsiveness and airflow limitation. Objective This study was aimed to analyse whether chronic inhalative allergen challenges in mice lead to morphological and physiological changes comparable with this phenotype. Methods For this purpose, BALB/c mice were systemically sensitized to ovalbumin (OVA) followed by aerosol allergen challenges on 2 consecutive days per week for 12 weeks. Results In chronically challenged mice, tissue inflammation in proximal as well as distal air…

Pathologymedicine.medical_specialtyAllergyOvalbuminImmunologyInflammationBronchiMiceTransforming Growth Factor betaAdministration InhalationmedicineImmunology and AllergyAnimalsRespiratory systemAsthmaMice Inbred BALB CMucous MembraneInhalationbusiness.industryRespiratory diseaserespiratory systemAllergensmedicine.diseaseAsthmarespiratory tract diseasesDisease Models Animalmedicine.anatomical_structureImmunologyChronic DiseaseDisease ProgressionCytokinesFemalemedicine.symptomBronchial HyperreactivityAirwaybusinessBronchoalveolar Lavage FluidRespiratory tractClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

The role of mast cells on angiogenesis in oral squamous cell carcinoma

2011

Objective: Angiogenesis or neovascularization has long been known to aid in progression and metastasis of malignant tumors. Tumor angiogenesis is a complex event mediated by angiogenic factors released from cancer cells and or by host immune cells. Mast cells may induce tumor progression and potentiate metastasis by stimulating angiogenesis. The purpose of the present study was to validate topographic distribution of micro vessel density (MVD) and mast cell density (MCD) and help to elucidate the possible role of mast cells in tumor angiogenesis and correlating this with advanced disease parameters. Study Design: MVD and MCD were investigated in tumor specimens from 30 patients diagnosed wi…

Pathologymedicine.medical_specialtyAngiogenesisMetastasisNeovascularizationmedicineCarcinomaHumansMast CellsGeneral DentistryMouth neoplasmOral Medicine and PathologyNeovascularization Pathologicbusiness.industry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMast cellstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyTumor progressionCancer cellUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellDisease ProgressionResearch-ArticleMouth NeoplasmsSurgerymedicine.symptombusiness
researchProduct

Hypoxia in Breast Cancer: Pathogenesis, Characterization and Biological/Therapeutic Implications

2002

Nearly 50% of locally advanced breast cancers exhibit hypoxic and/or anoxic tissue areas that are heterogeneously distributed within the tumour mass. Hypoxia is predominantly caused by structural and functional abnormalities of the newly formed tumour vessels arising from neovascularization, by a disturbed microcirculation, by enlarged diffusion distances, and by tumour-associated or therapy-induced anaemia. The extent of pretherapeutically measured hypoxic tissue areas is independent of clinical tumour size and stage, and histological type and grade. Anaemia can substantially worsen tumour O2 depletion. Hypoxia is known to directly or indirectly confer resistance to irradiation and some ch…

Pathologymedicine.medical_specialtyBreast NeoplasmsDisease-Free SurvivalTreatment failureMicrocirculationPathogenesisNeovascularizationBreast cancerHumansMedicineTreatment FailureNeovascularization Pathologicbusiness.industryMicrocirculationGeneral MedicineHypoxia (medical)Prognosismedicine.diseaseCell HypoxiaClinical trialCancer researchFemalemedicine.symptomMalignant progressionbusinessWiener Medizinische Wochenschrift
researchProduct

Ductal Carcinoma In Situ of the Breast: A Comparative Analysis of Histology, Nuclear Area, Ploidy, and Neovascularization Provides Differentiation Be…

2002

Ductal carcinoma in situ (DCIS) is a heterogeneous group of lesions that has been subdivided into three types: well differentiated (grade I), moderately differentiated (grade II), and poorly differentiated (grade III). Forty-five cases of DCIS were analyzed for image analysis: nuclear area, DNA ploidy, and vascularization in order to establish a more precise correlation between the histologic grade and these morphometric parameters. Our results confirm that the mean nuclear area, DNA ploidy, and microvessel density (MVD) progressively increased from DCIS grade I to DCIS grade III. The analysis of the nuclear area in relationship to DCIS grading demonstrated a progressive increase of values …

Pathologymedicine.medical_specialtyBreast NeoplasmsNeovascularizationStatistical significanceImage Processing Computer-AssistedInternal MedicineHumansMedicineNeoplasmskin and connective tissue diseasesneoplasmsGrading (tumors)Cell NucleusPloidiesNeovascularization Pathologicbusiness.industryCarcinoma in situCarcinoma Ductal BreastHistologyDNA NeoplasmDuctal carcinomamedicine.diseasebody regionsOncologyTumor progressionFemaleSurgerymedicine.symptombusinessCarcinoma in SituThe Breast Journal
researchProduct

Longitudinal 18F-FDG PET and MRI Reveal Evolving Imaging Pathology That Corresponds to Disease Progression in a Patient With ALS-FTD

2019

Single time point positron emission tomography (PET) studies of patients with amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD), have demonstrated hypometabolism or hypermetabolism in certain brain regions. To determine whether longitudinal (at baseline and 20.4 months later) PET and magnetic resonance imaging (MRI) reveal evolving brain imaging pathology corresponding to clinical progression in a patient with ALS-FTD, cerebral glucose metabolic rate, cortical thickness (CT) and cortical area (CA) were obtained and symmetric percent change (SPC) for each calculated. The patient had worsening symptoms and signs of bulbar-onset upper motor neuron-predominant ALS as well as l…

Pathologymedicine.medical_specialtyCase ReportLateralization of brain functionlcsh:RC346-429030218 nuclear medicine & medical imagingPrimary progressive aphasia03 medical and health sciences0302 clinical medicineNeuroimagingAphasiaALS-FTDMedicineAmyotrophic lateral sclerosislcsh:Neurology. Diseases of the nervous systemcortical areamedicine.diagnostic_testbusiness.industryMagnetic resonance imagingcortical thicknessmedicine.diseaseaphasiaPETNeurologyNeurology (clinical)medicine.symptombusinessNeurocognitive030217 neurology & neurosurgeryFrontotemporal dementiaMRIFrontiers in Neurology
researchProduct

Molecular Profiling of Potential Human Prostate Cancer Stem Cells

2013

We have investigated the expression of Oct-4, Suz-12, and Cripto-1, as presumptive “stemness” genes, and of connexin 43 (Cx43), Cx32 and androgen receptor (AR), as cell differentiation genes, in two human prostate cancer cell lines, PC3 and LNCaP. This aiming to define molecular profiles of prostate cancer stem cells for a better understanding of prostate carcinogenesis and tumor progression, as well as for prognostic or therapeutic purposes. Cells were grown in 3-dimensional (3D) cell cultures to favor clonal expansion of cancer stem and early progenitor cells, and compared to cells grown in 2-dimensional (2D) cell cultures. Under 3D culture conditions, LNCaP cells and PC3 cells generated …

Pathologymedicine.medical_specialtyCellular differentiationBiologymedicine.diseaseProstate cancerTumor progressionCancer stem cellCell cultureLNCaPmedicineCancer researchStem cellProgenitor cellJournal of Stem Cell Research & Therapy
researchProduct

Strong Expression of Chemokine Receptor CXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease

2008

Diverse chemokines and their receptors have been associated with tumor growth, tumor dissemination, and local immune escape. In different tumor entities, the level of chemokine receptorCXCR4 expression has been linked with tumor progression and decreased survival. The aim of this study was to evaluate the influence ofCXCR4 expression on the progression of human renal cell carcinoma.CXCR4 expression of renal cell carcinoma was assessed by immunohistochemistry in 113 patients. Intensity ofCXCR4 expression was correlated with both tumor and patient characteristics. Human renal cell carcinoma revealed variable intensities ofCXCR4 expression. StrongCXCR4 expression of renal cell carcinoma was si…

Pathologymedicine.medical_specialtyChemokineArticle Subjectbiologybusiness.industrymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCXCR4lcsh:RC254-282Chemokine receptorOncologyTumor progressionRenal cell carcinomaAdvanced diseasebiology.proteinMedicineImmunohistochemistrybusinessReceptorResearch ArticleJournal of Oncology
researchProduct

Rapid malignant progression of an intraparenchymal choroid plexus papillomas

2018

Background: Choroid plexus tumors (CPTs) are rare neoplasms accounting for only 0.3-0.6% of all brain tumors in adults and 2-5% in children. The World Health Organization (WHO) classification describes three histological grades: grade I is choroid plexus papilloma (CPP), grade II is atypical papilloma, and grade III is the malignant form of carcinoma. In adults, CPTs rarely have a supratentorial localization. Case Description: Here we report a very rare case of an intraparenchymal parietal CPP with a rapid histological transition from grade I to grade III WHO in a 67-year-old man, in <7 months. Conclusion: Because of the rarity of these oncotypes, descriptions of each new case are useful…

Pathologymedicine.medical_specialtyChoroid plexus atypical papillomaWorld health03 medical and health sciences0302 clinical medicineCarcinomaMedicinechoroid plexus papillomasSettore MED/27 - Neurochirurgiabusiness.industrychoroid plexus carcinomaGeneral Neurosurgery: Case Reportmalignant progressionChoroid plexus carcinomamedicine.diseaseChoroid plexus papilloma030220 oncology & carcinogenesischoroid plexus papillomaPapillomaSurgeryChoroid plexusNeurology (clinical)Histological gradesMalignant progressionbusinessWorld Health Organization classification030217 neurology & neurosurgerySurgical Neurology International
researchProduct